Hisamitsu Pharmaceutical Co., Inc. (HTSUF)
USD 24.56
(0.0%)
USD 24.56
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 141.7 Billion | 128.33 Billion | 120.19 Billion | 114.51 Billion | 140.99 Billion | 143.4 Billion |
| Cost of Revenue | 62.73 Billion | 55.63 Billion | 50.12 Billion | 45.33 Billion | 53.38 Billion | 54.72 Billion |
| Gross Profit | 78.97 Billion | 72.7 Billion | 70.06 Billion | 69.17 Billion | 87.6 Billion | 88.68 Billion |
| Operating Expenses | 65.8 Billion | 61.09 Billion | 60.73 Billion | 58.5 Billion | 64.87 Billion | 66.4 Billion |
| Selling, General and Administrative Expenses | 57.18 Billion | 51.31 Billion | 50.11 Billion | 47.73 Billion | 54.37 Billion | 53.36 Billion |
| Research and Development Expenses | 8.61 Billion | 9.78 Billion | 10.61 Billion | 10.76 Billion | 10.5 Billion | 13.03 Billion |
| Other Expenses | 57.18 Billion | 197 Million | 417 Million | 414 Million | 330 Million | 382 Million |
| Cost and Expenses | 128.53 Billion | 116.72 Billion | 110.85 Billion | 103.83 Billion | 118.26 Billion | 121.12 Billion |
| Operating Income | 13.16 Billion | 11.59 Billion | 9.33 Billion | 10.67 Billion | 22.72 Billion | 22.27 Billion |
| Interest Expense | 18 Million | 15 Million | 20 Million | 10 Million | 19 Million | 19 Million |
| Income Tax Expense | 4.75 Billion | 3.98 Billion | 3.09 Billion | 2.76 Billion | 7.24 Billion | 6.29 Billion |
| Earnings before Tax | 19.18 Billion | 16.11 Billion | 12.95 Billion | 12.19 Billion | 26.15 Billion | 25.67 Billion |
| Net Income | 13.96 Billion | 11.74 Billion | 9.65 Billion | 9.25 Billion | 18.69 Billion | 19.2 Billion |
| Earnings Per Share Basic | 181.42 | 148.00 | 118.92 | 113.21 | 227.58 | 230.08 |
| Earnings Per Share Diluted | 181.41 | 147.87 | 118.84 | 113.10 | 227.30 | 229.86 |
| Weighted Average Shares Outstanding | 76.99 Million | 79.34 Million | 81.21 Million | 81.7 Million | 82.14 Million | 83.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 77 Million | 79.4 Million | 81.27 Million | 81.78 Million | 82.24 Million | 83.54 Million |
| Gross Margin | 0.56 | 0.57 | 0.58 | 0.60 | 0.62 | 0.62 |
| EBIT Margin | 0.13 | 0.16 | 0.14 | 0.14 | 0.21 | 0.21 |
| Profit Margin | 0.10 | 0.09 | 0.08 | 0.08 | 0.13 | 0.13 |
| EBITDA | 18.34 Billion | 16.55 Billion | 13.65 Billion | 14.75 Billion | 26.98 Billion | 28.02 Billion |
| Earnings Before Tax Margin | 0.09 | 0.09 | 0.08 | 0.09 | 0.16 | 0.16 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 141.7 Billion | 38.87 Billion | 35.85 Billion | 34.88 Billion | 32.09 Billion | 128.33 Billion |
| Cost of Revenue | 62.73 Billion | 18.5 Billion | 15.89 Billion | 14.95 Billion | 13.37 Billion | 55.63 Billion |
| Gross Profit | 78.97 Billion | 20.37 Billion | 19.95 Billion | 19.92 Billion | 18.71 Billion | 72.7 Billion |
| Operating Expenses | 65.8 Billion | 19.47 Billion | 16.08 Billion | 15.89 Billion | 14.35 Billion | 61.09 Billion |
| Selling, General and Administrative Expenses | - | 16.9 Billion | 14.17 Billion | 13.63 Billion | 12.47 Billion | - |
| Research and Development Expenses | - | 2.57 Billion | 1.9 Billion | 2.26 Billion | 1.88 Billion | - |
| Other Expenses | 498 Million | 88 Million | 90 Million | 105 Million | 215 Million | 197 Million |
| Cost and Expenses | 128.53 Billion | 37.98 Billion | 31.97 Billion | 30.84 Billion | 27.73 Billion | 116.72 Billion |
| Operating Income | 13.16 Billion | 898 Million | 3.87 Billion | 4.03 Billion | 4.36 Billion | 11.59 Billion |
| Interest Expense | 18 Million | 6 Million | 5 Million | 7 Million | - | 15 Million |
| Income Tax Expense | 4.75 Billion | 575 Million | 1.21 Billion | 1.43 Billion | 1.53 Billion | 3.98 Billion |
| Earnings before Tax | 19.18 Billion | 2.52 Billion | 5.02 Billion | 5.92 Billion | 5.71 Billion | 16.11 Billion |
| Net Income | 13.96 Billion | 1.85 Billion | 3.69 Billion | 4.36 Billion | 4.04 Billion | 11.74 Billion |
| Earnings Per Share Basic | - | 24.54 | 48.52 | 56.25 | 52.08 | - |
| Earnings Per Share Diluted | - | 24.54 | 48.42 | 56.19 | 52.04 | - |
| Weighted Average Shares Outstanding | 76.91 Million | 75.74 Million | 76.1 Million | 77.65 Million | 77.74 Million | 79.34 Million |
| Weighted Average Shares Outstanding (Diluted) | 77 Million | 75.74 Million | 76.27 Million | 77.73 Million | 77.81 Million | 79.4 Million |
| Gross Margin | 0.56 | 0.52 | 0.56 | 0.57 | 0.58 | 0.57 |
| EBIT Margin | - | 0.06 | 0.14 | 0.15 | 0.18 | - |
| Profit Margin | 0.10 | 0.05 | 0.10 | 0.13 | 0.13 | 0.09 |
| EBITDA | - | 2.35 Billion | 5.04 Billion | 5.35 Billion | 5.71 Billion | - |
| Earnings Before Tax Margin | 0.09 | 0.02 | 0.11 | 0.12 | 0.14 | 0.09 |
4687
BVS
VOPKY
6248
O10
ACPS